Evaluation of 11C-LSN3172176 as a Novel PET Tracer for Imaging M1 Muscarinic Acetylcholine Receptors in Nonhuman Primates
Nabeel B Nabulsi, Daniel Holden, Ming-Qiang Zheng, Frederic Bois, Shu-Fei Lin, Soheila Najafzadeh, Hong Gao, Jim Ropchan, Teresa Lara-Jaime, David Labaree, Anupama Shirali, Lawrence Slieker, Cynthia Jesudason, Vanessa Barth, Antonio Navarro, Nancy Kant, Richard E Carson, Yiyun Huang, Nabeel B Nabulsi, Daniel Holden, Ming-Qiang Zheng, Frederic Bois, Shu-Fei Lin, Soheila Najafzadeh, Hong Gao, Jim Ropchan, Teresa Lara-Jaime, David Labaree, Anupama Shirali, Lawrence Slieker, Cynthia Jesudason, Vanessa Barth, Antonio Navarro, Nancy Kant, Richard E Carson, Yiyun Huang
Abstract
The M1 muscarinic acetylcholine receptor (mAChR) plays an important role in learning and memory, and therefore is a target for development of drugs for treatment of cognitive impairments in Alzheimer disease and schizophrenia. The availability of M1-selective radiotracers for PET will help in developing therapeutic agents by providing an imaging tool for assessment of drug dose-receptor occupancy relationship. Here we report the synthesis and evaluation of 11C-LSN3172176 (ethyl 4-(6-(methyl-11C)-2-oxoindolin-1-yl)-[1,4'-bipiperidine]-1'-carboxylate) in nonhuman primates. Methods:11C-LSN3172176 was radiolabeled via the Suzuki-Miyaura cross-coupling method. PET scans in rhesus macaques were acquired for 2 h with arterial blood sampling and metabolite analysis to measure the input function. Blocking scans with scopolamine (50 μg/kg) and the M1-selective agent AZD6088 (0.67 and 2 mg/kg) were obtained to assess tracer binding specificity and selectivity. Regional brain time-activity curves were analyzed with the 1-tissue-compartment model and the multilinear analysis method (MA1) to calculate regional distribution volume. Nondisplaceable binding potential values were calculated using the cerebellum as a reference region. Results:11C-LSN3172176 was synthesized with greater than 99% radiochemical purity and high molar activity. In rhesus monkeys, 11C-LSN3172176 metabolized rapidly (29% ± 6% parent remaining at 15 min) and displayed fast kinetics and extremely high uptake in the brain. Imaging data were modeled well with the 1-tissue-compartment model and MA1 methods. MA1-derived distribution volume values were high (range, 10-81 mL/cm3) in all known M1 mAChR-rich brain regions. Pretreatment with scopolamine and AZD6088 significantly reduced the brain uptake of 11C-LSN3172176, thus demonstrating its binding specificity and selectivity in vivo. The cerebellum appeared to be a suitable reference region for derivation of nondisplaceable binding potential, which ranged from 2.42 in the globus pallidus to 8.48 in the nucleus accumbens. Conclusion:11C-LSN3172176 exhibits excellent in vivo binding and imaging characteristics in nonhuman primates and appears to be the first appropriate radiotracer for PET imaging of human M1 AChR.
Keywords: 11C-LSN3172176; M1 AChR; PET; muscarinic; non-human primates; radioligand; scopolamine.
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Source: PubMed